3 results
Approved WMORecruitment stopped
see Background
Approved WMORecruitment stopped
The primary objective is to gain experience with primary radiochemotherapy and to determine the locoregional response rate at 12 weeks after radiochemotherapy and after groin dissection for cN1,2 patients.
Approved WMORecruiting
This study has been transitioned to CTIS with ID 2024-512862-32-00 check the CTIS register for the current data. The primary objectives of this trial are to study clinical efficacy and immune activation of neoadjuvant PD-1 blockade in VSCC.